Valanafusp Alfa structure
|
Common Name | Valanafusp Alfa | ||
---|---|---|---|---|
CAS Number | 1815583-32-4 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | N/A | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Valanafusp AlfaValanafusp alfa (AGT-181) is a brain penetrating recombinant fusion protein of a chimeric monoclonal antibody against the human insulin receptor (HIR) and human iduronidase (IDUA). Valanafusp alfa can be used for the research of Mucopolysaccharidosis type I (MPS I) [1]. |
Name | Valanafusp Alfa |
---|
Description | Valanafusp alfa (AGT-181) is a brain penetrating recombinant fusion protein of a chimeric monoclonal antibody against the human insulin receptor (HIR) and human iduronidase (IDUA). Valanafusp alfa can be used for the research of Mucopolysaccharidosis type I (MPS I) [1]. |
---|---|
Related Catalog | |
In Vitro | Valanafusp alfa (HIRMAb-IDUA) 与 HIR 胞外结构域 (ECD) 结合,EC50 为 0.93±0.07 nM[2]。 Valanafusp alfa (HIRMAb-IDUA) (0.3 μg/mL; 48 h) 与健康成纤维细胞相比,可使 Hurler 成纤维细胞中的糖氨基聚糖积累减少 70%[2]。 |
In Vivo | Valanafusp alfa (AGT-181) (0.2-20 mg/kg; IV) 慢性给药在所有剂量下都具有极好的安全性,并且对血浆或脑脊液的血糖控制没有影响[1]。 Valanafusp alfa (AGT-181) (0.2-20 mg/kg; IV) 在 Rhesus monkeys 体内稳定,清除率快,分布量大[1]。 |
References |
No Any Chemical & Physical Properties |